Onderneming SINCLAIR IS PHARMA Euronext Paris
Aandelen
GB0033856740
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- EUR | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Miguel Pardos
CEO | Chief Executive Officer | - | 01-06-22 |
Santiago Calavia
PRN | Corporate Officer/Principal | - | - |
Julie Moreau
PRN | Corporate Officer/Principal | - | - |
Kamal Abbasi
PRN | Corporate Officer/Principal | - | - |
Jayne Burrell
LAW | General Counsel | 50 | 02-01-15 |
Nairn McMaster
PRN | Corporate Officer/Principal | - | 01-07-11 |
Emilie Croissant
SAM | Sales & Marketing | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Cheng Wei Liu
CHM | Chairman | 50 | - |
Miguel Pardos
CEO | Chief Executive Officer | - | 01-06-22 |
Gen Li
BRD | Director/Board Member | - | 27-04-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 580 157 084 | 315 849 061 ( 54,44 %) | 0 | 54,44 % |
Bedrijfsgegevens
Sinclair Pharma Ltd.
Whitfield Court 30-32 Whitfield Street
W1T 2RQ, London
+44 20 7467 6920
http://www.sinclairpharma.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+21,98% | 43,92 mld. | |
+24,56% | 23,09 mld. | |
+19,14% | 15,35 mld. | |
+14,03% | 13,61 mld. | |
+46,40% | 12,02 mld. | |
-10,14% | 7 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+13,07% | 5,6 mld. |